Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients
Conditions: Prediabetic State; Impaired Fasting Glucose; Impaired Glucose Tolerance Interventions: Drug: Dapagliflozin 10mg Tab; Behavioral: lifestyle interventions Sponsors: Yangjin; Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials